Shouzheng Wang
- Oncology top 10%
- Lung Cancer Research Studies 9
-
- Lung Cancer Treatments and Mutations 16
- Aortic Disease and Treatment Approaches 11
- Cardiovascular and Diving-Related Complications 8
-
- Cardiac Valve Diseases and Treatments 28
-
- Congenital Heart Disease Studies 16
- Infective Endocarditis Diagnosis and Management 14
-
- Cardiac Structural Anomalies and Repair 15
- Journals
- Circulation (1 paper)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Shouzheng Wang
80 papers receiving 788 citations
Peers
Comparison fields: 5 of 104
- Oncology 274
- Pulmonary and Respiratory Medicine 300
- Cardiology and Cardiovascular Medicine 166
- Epidemiology 216
- Health Informatics 7
Countries citing papers authored by Shouzheng Wang
This map shows the geographic impact of Shouzheng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shouzheng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shouzheng Wang more than expected).
Fields of papers citing papers by Shouzheng Wang
This network shows the impact of papers produced by Shouzheng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shouzheng Wang. The network helps show where Shouzheng Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shouzheng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 0 | |
| 12 | Efficacy of Osimertinib After Progression of First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) in EGFR-Mutated Lung Adenocarcinoma: A Real-World Study in Chinese Patients | 2022 | 3 |
| 13 | 2021 | 13 | |
| 14 | 2021 | 32 | |
| 15 | 2019 | 8 | |
| 16 | 2019 | 8 | |
| 17 | 2019 | 141 | |
| 18 | 2018 | 6 | |
| 19 | 2016 | 1 | |
| 20 | 2014 | 47 |
About Shouzheng Wang
Shouzheng Wang is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology, having authored 90 papers that have together received 796 indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (28 papers), Lung Cancer Treatments and Mutations (16 papers), Congenital Heart Disease Studies (16 papers), Cardiac Structural Anomalies and Repair (15 papers), Infective Endocarditis Diagnosis and Management (14 papers), Aortic Disease and Treatment Approaches (11 papers), Lung Cancer Research Studies (9 papers) and Cardiovascular and Diving-Related Complications (8 papers). The work is most often cited by research in Oncology (274 citations), Pulmonary and Respiratory Medicine (300 citations) and Cardiology and Cardiovascular Medicine (166 citations). Shouzheng Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Junling Li, Puyuan Xing, Wenbin Ouyang, Xiangbin Pan, Yan Wang, Fengwen Zhang, Yiying Guo, Xuezhi Hao, Yu Xu and Guoqiang Wang. Their work appears in journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.